Healthcare provider profile · identity verified

Malcolm Lakdawala

Family Practice · BEVERLY HILLS, CA · NPI 1669900536

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	507	197
Amlodipine Besylate	Amlodipine Besylate	328	127
Lisinopril	Lisinopril	285	101
Gabapentin	Gabapentin	229	90
Levothyroxine Sodium	Levothyroxine Sodium	216	86
Losartan Potassium	Losartan Potassium	214	89
Rosuvastatin Calcium	Rosuvastatin Calcium	166	53
Metformin Hcl	Metformin Hcl	160	65
Glipizide	Glipizide	143	51
Sertraline Hcl	Sertraline Hcl	141	48
Omeprazole	Omeprazole	109	44
Pantoprazole Sodium	Pantoprazole Sodium	106	42
Hydrochlorothiazide	Hydrochlorothiazide	97	36
Metoprolol Succinate	Metoprolol Succinate	87	34
Simvastatin	Simvastatin	84	31
Duloxetine Hcl	Duloxetine Hcl	82	27
Tamsulosin Hcl	Tamsulosin Hcl	79	28
Fluticasone Propionate	Fluticasone Propionate	77	39
Carvedilol	Carvedilol	75	34
Bupropion Xl	Bupropion Hcl	74	26
Pravastatin Sodium	Pravastatin Sodium	73	26
Albuterol Sulfate Hfa	Albuterol Sulfate	71	33
Furosemide	Furosemide	65	27
Spironolactone	Spironolactone	63	21
Metoprolol Tartrate	Metoprolol Tartrate	61	22
Trazodone Hcl	Trazodone Hcl	61	28
Methocarbamol	Methocarbamol	60	26
Montelukast Sodium	Montelukast Sodium	56	21
Ozempic	Semaglutide	56	22
Allopurinol	Allopurinol	50	22
Baclofen	Baclofen	50	19
Januvia	Sitagliptin Phosphate	49	15
Jardiance	Empagliflozin	48	18
Azelastine Hcl	Azelastine Hcl	46	32
Eliquis	Apixaban	45	18
Pioglitazone Hcl	Pioglitazone Hcl	41	14
Ezetimibe	Ezetimibe	39	15
Clopidogrel	Clopidogrel Bisulfate	36	17
Potassium Chloride	Potassium Chloride	36	16
Alendronate Sodium	Alendronate Sodium	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	11
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	13
Doxycycline Monohydrate	Doxycycline Monohydrate	27	22
Famotidine	Famotidine	27	15
Gemtesa	Vibegron	27	suppressed
Memantine Hcl	Memantine Hcl	25	12
Metformin Hcl Er	Metformin Hcl	25	11
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	12
Meloxicam	Meloxicam	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Pregabalin	Pregabalin	21	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	16
Atenolol	Atenolol	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	11
Lovastatin	Lovastatin	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	11
Finasteride	Finasteride	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Ramelteon	Ramelteon	17	suppressed
Torsemide	Torsemide	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nexlizet	Bempedoic Acid/Ezetimibe	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error